The Centers for Medicare & Medicaid Services seeks input on rulemaking to require electronic prescribing for controlled substances covered by Medicare Part D and Medicare Advantage prescription drug plans beginning Jan. 1, in accordance with the Substance Use-Disorder Prevention that Promotes Opioid Recover and Treatment for Patients and Communities Act of 2018.

The request for information asks whether there should be exceptions to the requirement and under what circumstances, and whether CMS should impose penalties for noncompliance. Comments are due Oct. 3.

Related News Articles

Headline
The House of Representatives last night voted 233-188 along party lines to pass a $1.5 trillion bill (H.R. 2) introduced by Democratic leaders to rebuild…
Headline
Regular surveys and reviews by The Joint Commission will resume this month, the commission announced last week. TJC, which had suspended surveys during the…
Headline
The Department of Health and Human Services Tuesday reminded health care providers that HIPAA privacy rules bar them from giving media and film crews access to…
Headline
Members of the Partnership to Amend 42 CFR Part 2, including the AHA, today urged the Department of Health and Human Services to issue a rule as soon as…
Headline
The Department of Health and Human Services’ Office for Civil Rights yesterday said it generally will not impose penalties for HIPAA rule violations on health…
Headline
The Department of Health and Human Services' Office for Civil Rights April 3 warned HIPAA-covered entities of an individual posing as an OCR investigator…